Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Abstract Highlights from EHA 2022 : A Spotlight on Lymphoma

    July 26, 2022 | CME, Medscape Oncology, medical education 

    - PMLiVE

    Spotlight on Lymphoma

    Ahead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Dr Loretta Nastoupil, US, on the most important abstracts to look out for in lymphoma. Here are some of the highlights…

    1. Update on the ECHELON-1 study in frontline Hodgkin lymphoma, where an OS advantage was seen when bleomycin was replaced with brentuximab vedotin in frontline, ABVD, which is potentially practice-changing.
    2. The results of the Ph 3 SHINE study have been eagerly awaited for many years in untreated mantle cell lymphoma, and showed a significant improvement in PFS with ibrutinib + bendamustine + rituximab and rituximab maintenance vs standard chemoimmunotherapy.
    3. Positive Ph 2 efficacy data with the bispecific antibodies, glofitamab for relapsed/refractory (R/R) diffuse large B-cell lymphoma, and mosunetuzumab for R/R follicular lymphoma, building on the Ph 1 data previously reported.
    4. Other CAR T-cell therapies with novel targets and in other indications are emerging, such as for T-cell lymphoma where there is a high unmet need for new therapies. Some manipulations to manufacturing also result in an auto CAR within 2 days. So, while CAR T-cell therapy is not new, there are new implementations of therapy that have been around for several years.
    5. Important to now learn regarding patient selection, sequencing CD19 directed therapy and how to account for the patient experience for which there will also be more PRO data reported.

    You can also watch the full video here

    About Medscape:
    Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. Medscape is the leading online global destination for physicians and healthcare professionals, providing over 5 million members with the latest medical news, expert opinion, and precision education (CME and CPD) to improve clinical practice and advance health outcomes. Medscape’s unrivalled membership reach and therapeutic expertise deliver education across 30+ specialties in 40+ learning formats, using the latest digital and live technology.

    This content was provided by Medscape Education

    Company Details

    Medscape Logo

    Medscape Education

    Email
    Website

     Latest Content from  Medscape Education 

    Everything Was Peachy at ACC 2024 in Atlanta, GA

    The annual ACC meeting has officially wrapped up in Atlanta, bringing a successful conference to a close for another year.  During the conference, members of the Medscape team hosted a...

    A Woman Should Not Be Treated As a Small Man

    What should the future of women’s healthcare look like? Two renowned physicians say it involves a multidisciplinary, holistic approach, where a group of different specialists work together to provide a...

    Sharing Four Times the Impact at ACC 2024

    ACC is kicking off next week in Atlanta, GA, and Medscape is heading south to join our cardiology colleagues. The Medscape team will be hosting booth #3431 on the exhibit...

    Transforming San Diego for AAD 2024

    The 2024 meeting of the American Academy of Dermatology has wrapped up, and Medscape has returned from a series of successful days at their booth, symposia, and offsite event. To...

    The Power Dynamics of Women and Cancer

    Women, Power, and Cancer: a Lancet commission, studied the interaction of women and cancer through a social justice and equity lens. What does ‘power’ mean when it comes to cancer...

    Evaluating the Forces Shaping Women’s Healthcare

    Gaps in women’s healthcare go beyond access and cost. Do clinicians have the tools they need to understand women’s health?

    Shortening the Journey at the Unusual Suspects Meeting

    Medscape will be continuing their mission to shorten the diagnostic journey for patients with a rare disease at this year’s Unusual Suspects event on February 21.The Unusual Suspects is an...

    Did You Hear From Her? If Not Here’s What You Missed in Season 1 of the Award-Winning Season Podcast Series

    What are some of the biggest gaps that women face in healthcare today?  “So many I could talk for hours!” said Shikha Jain, MD, FACP, President, CEO, Founder Women in Medicine....

    Have you heard from her?

    We’re referring to the renowned women leaders from across the healthcare landscape who were our guests on Season 1 of Medscape Education’s Hear From Her podcast series. The conversations touched...

    Rare Disease Diagnostic Odyssey